Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nils Bomer

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Stem Cells Translational Medicine|October 11, 2018
Concise Review: The Current State of Human In Vitro Cardiac Disease Modeling: A Focus on Gene Editing and Tissue EngineeringMartijn F Hoes, Nils Bomer, Peter van der Meer
Current Heart Failure Reports|April 9, 2021
Selenium, Selenoproteins, and Heart Failure: Current Knowledge and Future PerspectiveAli A Al-Mubarak, Peter van der Meer, Nils Bomer
Best Practice & Research. Clinical Rheumatology|April 25, 2016
Translating genomics into mechanisms of disease: OsteoarthritisNils Bomer, Wouter den Hollander, Yolande F M Ramos, et al.
Current Heart Failure Reports|June 14, 2022
Review: Precision Medicine Approaches for Genetic Cardiomyopathy: Targeting Phospholamban R14delFrederik E Deiman, Nils Bomer, Peter van der Meer, et al.
European Journal of Heart Failure|May 14, 2024
404-error "Disease not found": Unleashing the translational potential of -omics approaches beyond traditional disease classification in heart failure researchAntonio Esquivel Gaytan, Nils Bomer, Niels Grote Beverborg, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|March 6, 2025
Identification of disease-specific pathways and modifiers in phospholamban R14del cardiomyopathy: rationale, design and baseline characteristics of DECIPHER-PLN cohortFrederik E Deiman, Remco de Brouwer, Lukas Baumhove, et al.
Npj Aging|January 23, 2024
A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and agingAnnet Nicole Linders, Itamar Braga Dias, Teresa López Fernández, et al.
Nutrients|January 11, 2025
Micronutrient Deficiencies in Heart Failure and Relationship with Exocrine Pancreatic InsufficiencyMarlene A T Vijver, Nils Bomer, Robert C Verdonk, et al.
Journal of Cardiovascular Translational Research|October 30, 2025
RNA Therapeutics in Heart FailureFrederik E Deiman, Myrthe M de Graaf, Herman H W Sillje, et al.
Nature Reviews. Cardiology|September 14, 2023
Immunomodulation and immunopharmacology in heart failureGeorge Markousis-Mavrogenis, Lukas Baumhove, Ali A Al-Mubarak, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Stem Cells Translational Medicine|October 11, 2018
Concise Review: The Current State of Human In Vitro Cardiac Disease Modeling: A Focus on Gene Editing and Tissue EngineeringMartijn F Hoes, Nils Bomer, Peter van der Meer
Current Heart Failure Reports|April 9, 2021
Selenium, Selenoproteins, and Heart Failure: Current Knowledge and Future PerspectiveAli A Al-Mubarak, Peter van der Meer, Nils Bomer
Best Practice & Research. Clinical Rheumatology|April 25, 2016
Translating genomics into mechanisms of disease: OsteoarthritisNils Bomer, Wouter den Hollander, Yolande F M Ramos, et al.
Current Heart Failure Reports|June 14, 2022
Review: Precision Medicine Approaches for Genetic Cardiomyopathy: Targeting Phospholamban R14delFrederik E Deiman, Nils Bomer, Peter van der Meer, et al.
European Journal of Heart Failure|May 14, 2024
404-error "Disease not found": Unleashing the translational potential of -omics approaches beyond traditional disease classification in heart failure researchAntonio Esquivel Gaytan, Nils Bomer, Niels Grote Beverborg, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|March 6, 2025
Identification of disease-specific pathways and modifiers in phospholamban R14del cardiomyopathy: rationale, design and baseline characteristics of DECIPHER-PLN cohortFrederik E Deiman, Remco de Brouwer, Lukas Baumhove, et al.
Npj Aging|January 23, 2024
A review of the pathophysiological mechanisms of doxorubicin-induced cardiotoxicity and agingAnnet Nicole Linders, Itamar Braga Dias, Teresa López Fernández, et al.
Nutrients|January 11, 2025
Micronutrient Deficiencies in Heart Failure and Relationship with Exocrine Pancreatic InsufficiencyMarlene A T Vijver, Nils Bomer, Robert C Verdonk, et al.
Journal of Cardiovascular Translational Research|October 30, 2025
RNA Therapeutics in Heart FailureFrederik E Deiman, Myrthe M de Graaf, Herman H W Sillje, et al.
Nature Reviews. Cardiology|September 14, 2023
Immunomodulation and immunopharmacology in heart failureGeorge Markousis-Mavrogenis, Lukas Baumhove, Ali A Al-Mubarak, et al.
Pageof 5